Dr. Robert Gilman of A.B. PRISMA in Peru proposes to develop a rapid method of evaluating treatment response to tuberculosis and multidrug-resistant TB by measuring exhaled nitric oxide. Preliminary data has shown that patients with MDR-TB exhibit elevated levels of FeNO, and identifying these patients early can lead to alternative treatments to reduce transmission.
Grant ID
OPP1025545
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False